Haematological Disease

Haematological Disease

Show other versions (1)

Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...

Descrición completa

Detalles Bibliográficos
Main Authors:	Estcourt, L, Stanworth, S, Murphy, M
Formato:	Book section
Publicado:	John Wiley and Sons 2013

Títulos similares

Haematological Disease
por: Murphy, M, et al.
Publicado: (2009)

Platelet transfusions for patients with haematological malignancies: who needs them?
por: Estcourt, L, et al.
Publicado: (2011)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
por: Estcourt, L, et al.
Publicado: (2014)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
por: Estcourt, L, et al.
Publicado: (2017)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
por: Estcourt, L, et al.
Publicado: (2016)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
por: Wardrop, D, et al.
Publicado: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
por: Wardrop, D, et al.
Publicado: (2013)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
por: Desborough, M, et al.
Publicado: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
por: Estcourt, L, et al.
Publicado: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
por: Estcourt, L, et al.
Publicado: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
por: Estcourt, L, et al.
Publicado: (2015)

Prophylactic platelet transfusions
por: Estcourt, L, et al.
Publicado: (2010)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
por: Estcourt, L, et al.
Publicado: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
por: Estcourt, L, et al.
Publicado: (2015)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
por: Estcourt, L, et al.
Publicado: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
por: Estcourt, L, et al.
Publicado: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
por: Estcourt, L, et al.
Publicado: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
por: Estcourt, L, et al.
Publicado: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study
por: Estcourt, L, et al.
Publicado: (2014)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
por: Stanworth, S, et al.
Publicado: (2006)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
por: Estcourt, L, et al.
Publicado: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
por: Stanworth, S, et al.
Publicado: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
por: Stanworth, S, et al.
Publicado: (2014)

2016 National audit of red cell use in adult haematology patients
por: Karakantza, M, et al.
Publicado: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
por: Crighton, GL, et al.
Publicado: (2015)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
por: Butler, C, et al.
Publicado: (2011)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
por: Crighton, GL, et al.
Publicado: (2021)

Pathogen-reduced platelets for the prevention of bleeding (Review)
por: Estcourt, L, et al.
Publicado: (2017)

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
por: Estcourt, L, et al.
Publicado: (2017)

Pathogen-reduced platelets for the prevention of bleeding (Review)
por: Butler, C, et al.
Publicado: (2013)

Pathogen-reduced platelets for the prevention of bleeding.
por: Butler, C, et al.
Publicado: (2013)

Transfusion practice and safety: current status and possibilities for improvement.
por: Murphy, M, et al.
Publicado: (2011)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews 2. Analysis of the combined results from the included studies.
por: Hyde, C, et al.
Publicado: (2008)

Evidence for indications of fresh frozen plasma.
por: Stanworth, S, et al.
Publicado: (2007)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews.
por: Hyde, C, et al.
Publicado: (2008)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
por: Campbell, H, et al.
Publicado: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
por: Campbell, H, et al.
Publicado: (2014)

Platelet transfusions in haematology patients: are we using them appropriately?
por: Estcourt, L, et al.
Publicado: (2012)

Alternatives to allogeneic platelet transfusion
por: Desborough, M, et al.
Publicado: (2016)

Putting clinical trials into context.
por: Hyde, C, et al.
Publicado: (2005)